Genprex is a gene therapy company developing treatments for cancer and diabetes. Its cancer therapies are based upon a technology platform, including its lead drug candidate, Oncoprex immunogene therapy, or Oncoprex, for non-small cell lung cancer that consists of a tumor suppressor gene inserted into a patient’s cells that has immunomodulatory effects.